| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/12/2002 | US20020128591 Transdermal electrotransport device and method for manufacturing same |
| 09/12/2002 | US20020128527 Use in medicine, pharmacy, biology and technology, friction-reducing additives in engines |
| 09/12/2002 | US20020128345 High molecular weight rubber and less than about 60 parts by weight of a liquid diluent, and having a G' of less than about 15 x 104 dynes/cm2 at 10 rad/s at 25 degrees C. |
| 09/12/2002 | US20020128326 Topical immunomodulating compositions for treatment of aids, hepatitis b&c, other infectious diseases, and cancer |
| 09/12/2002 | US20020128322 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 09/12/2002 | US20020128314 Suppository comprising: a prostaglandin vasodilator; 15-hydroxyprostaglandindehydrogenase inhibitor: and a base material that is solid at room temperature and releases the components when inserted in the urethra, |
| 09/12/2002 | US20020128310 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammtory formulation |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128305 Administering an indole derivative such as 1-(4-(2-Azepan-1yl-ethoxy)-benzyl)-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5 -o l, or 2-(4-Hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl ethoxy)-benzyl)-1H-indol-5-ol |
| 09/12/2002 | US20020128293 Water insoluble polymer, such as crosslinked polyvinylpyrrolidone or vinyl acetate-vinylpyrrolidone copolymer, as a carrier which acts as a stabilizing excipient |
| 09/12/2002 | US20020128291 Following surgery or trauma or resulting in ocular diseases associated with choroidal neovascularization, such as age related macular degeneration and histoplasmosis syndrome |
| 09/12/2002 | US20020128289 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 09/12/2002 | US20020128285 Topical delivery of a local anesthetic |
| 09/12/2002 | US20020128269 Piperazine derivatives |
| 09/12/2002 | US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone |
| 09/12/2002 | US20020128251 Novel formulation |
| 09/12/2002 | US20020128241 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| 09/12/2002 | US20020128227 Beta-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 09/12/2002 | US20020128225 Methods and products related to pulmonary delivery of polysaccharides |
| 09/12/2002 | US20020128222 Methods to enhance wound healing and enhanced wound coverage material |
| 09/12/2002 | US20020128218 Therapeutic delivery compositions and methods of use thereof |
| 09/12/2002 | US20020128207 Dried blood factor composition comprising trehalose |
| 09/12/2002 | US20020128204 Pharmaceutical formulation for intravenous or intramuscular octreotide administration |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/12/2002 | US20020128193 Retro-inverso prosaposin-derived peptides and use thereof |
| 09/12/2002 | US20020128183 Gene regulation therapy involving ferritin |
| 09/12/2002 | US20020128179 To be aerosolizable by dry powder nebulizers, liquid nebulizers, and electrostatic sprayers |
| 09/12/2002 | US20020128177 For protecting a chemical compound from degradation |
| 09/12/2002 | US20020127635 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127321 Process for producing a powder containing crystalline particles of maltitol |
| 09/12/2002 | US20020127303 Used for multivitamin tablets, hard gelatin capsules, dry food and feed compositions and for enriching sugar |
| 09/12/2002 | US20020127281 Stabilized hyrogen peroxide solutions |
| 09/12/2002 | US20020127278 Dissolving the organic compound in the water-miscible first solvent to form a solution, mixing solution with second solvent to define a pre-suspension; adding energy to the pre-suspension to form particles |
| 09/12/2002 | US20020127277 Solid dosage forms of divalproex sodium |
| 09/12/2002 | US20020127276 Bio-erodible microbicidal devices for prevention of sexually transmitted diseases; retains antiviral activity at neutral pH and thus does not lose activity in the presence of seminal fluid; vaginal sponge with built-in microbicidal activity |
| 09/12/2002 | US20020127275 Slow release pharmaceutical compositions and methods of preparation |
| 09/12/2002 | US20020127274 Method of making ibuprofen and narcotic analgesic compositions |
| 09/12/2002 | US20020127273 Liposomal nystatin treatment of fungal infection |
| 09/12/2002 | US20020127272 For use as delivery vehicles for biologically active molecules |
| 09/12/2002 | US20020127271 Formulation for the treatment and/or prophylaxis of dementia |
| 09/12/2002 | US20020127266 Barrier or drug delivery system; time-release agents, biodegradable and biocompatible, therapy |
| 09/12/2002 | US20020127262 Method for preparing hydroxyapatite composite and biocompatible material |
| 09/12/2002 | US20020127254 Devices for local and systemic delivery of active substance and methods of manufacturing thereof |
| 09/12/2002 | US20020127253 Stable hydroalcoholic compositions |
| 09/12/2002 | US20020127251 For use in make-up such as foundations, powders, mascaras, eyeliners, lipsticks or products for making up the hair, deodorant products, in particular in the form of sticks or cream, protection creams, wipes |
| 09/12/2002 | US20020127250 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 09/12/2002 | US20020127249 Novel formulation for use in pain management |
| 09/12/2002 | US20020127223 Binding antibodies or antiboy-comparable with affinity for body cells not meant to be affected by chemotherapeutical drug directly to an antidote or to carriers such as proteins, or microbody carriers such as liposomes, erythroctes |
| 09/12/2002 | US20020127220 Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract- |
| 09/12/2002 | US20020127212 Use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | US20020127191 Emulsifier-free finely dispersed systems of the water-in-oil type |
| 09/12/2002 | US20020127190 Mucoadhesive film, of a homogeneous mixture of a water-soluble polymer, a polyalcohol, a cosmetically and/or pharmaceutically active agent, and a flavor |
| 09/12/2002 | US20020127189 Useful for supporting thermogenesis and anorectic effects, while generating enhanced mental alertness and improved energy levels |
| 09/12/2002 | US20020127188 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid |
| 09/12/2002 | US20020127187 Administering aerosol particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension to treat allergic rhinitis and asthma |
| 09/12/2002 | US20020127186 Use of electrolytes (lons in solution) to suppress charging of inhalation aerosols |
| 09/12/2002 | US20020127185 Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide |
| 09/12/2002 | US20020127184 Effervescent tablet compositions |
| 09/12/2002 | US20020127181 Antagonist diamidediphenolate compounds attached to a metal chelate and linking group; use as contrast agents for X-ray imaging and magnetic resonance imaging |
| 09/12/2002 | US20020125164 Personal medical dispensing card |
| 09/12/2002 | US20020124852 Method of treating diabetes mellitus in a patient |
| 09/12/2002 | DE10111058A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten New pharmaceutical compositions based on anticholinergics and NK¶1¶ receptor antagonists |
| 09/12/2002 | DE10110855A1 Use of glycerine carbonate and its derivatives e.g. as solvent for production of dyes and paints, in cosmetic compositions, in washing and cleansing agents and in adhesives |
| 09/12/2002 | DE10110772A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren New pharmaceutical compositions based on anticholinergics and PDE IV inhibitors |
| 09/12/2002 | DE10110336A1 Tensidfreie kosmetische, dermatologische und pharmazeutische Mittel Surfactant-free cosmetic, dermatological and pharmaceutical agents |
| 09/12/2002 | DE10108851A1 Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten Use of 5'-substituted nucleosides and / or their prodrugs for the resistance-free therapy of infectious diseases |
| 09/12/2002 | DE10107261A1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 09/12/2002 | CA2445308A1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof |
| 09/12/2002 | CA2445305A1 Method for making water soluble a poorly water-soluble antiseptic |
| 09/12/2002 | CA2442396A1 Method and formula for anti-tumor and anti-matastatic effect |
| 09/12/2002 | CA2440365A1 Use of a spray-dried powder comprising a sugar alcohol |
| 09/12/2002 | CA2440361A1 Intraorally rapidly disintegrable preparation |
| 09/12/2002 | CA2440141A1 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | CA2440070A1 Pharmaceutical composition made of cannabis extracts |
| 09/12/2002 | CA2440069A1 Taste masked pharmaceutical compositions |
| 09/12/2002 | CA2439915A1 New pharmaceutical compositions based on anticholinergics and nk1-receptor antagonists |
| 09/12/2002 | CA2439873A1 Intraorally rapidly desintegrable tablet |
| 09/12/2002 | CA2439859A1 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 09/12/2002 | CA2439820A1 Benzophenones as inhibitors of reverse transcriptase |
| 09/12/2002 | CA2439460A1 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
| 09/12/2002 | CA2438849A1 Compounds and compositions for delivering active agents |
| 09/12/2002 | CA2438847A1 Amphotericin b aqueous composition |
| 09/12/2002 | CA2438508A1 Fluid delivery device and associated method |
| 09/12/2002 | CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/11/2002 | EP1238677A2 Parenteral fat emulsions comprising edetate as preservative |
| 09/11/2002 | EP1238673A1 Colistin sulfate granules |
| 09/11/2002 | EP1238665A1 Method for dispensing s-adenosyl-methionine in a micro fine powdered form by inhalation |
| 09/11/2002 | EP1238664A1 Adhesive preparations |
| 09/11/2002 | EP1238663A2 Mixed hydrophilic gels as controlled release vehicles or floating dispersants |
| 09/11/2002 | EP1238662A2 Method for manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules |
| 09/11/2002 | EP1238661A1 Powdery inhalational preparations and process for producing the same |
| 09/11/2002 | EP1238660A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238659A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238658A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238657A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238656A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238647A1 Use of polyaminoacid derivatives as hydrating agents and cosmetic and pharmaceutical compositions containing them |